Segluromet
Payments companies reported to CMS as associated with Segluromet. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Segluromet, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Segluromet
These are the largest totals companies reported as associated with Segluromet. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mark Hodges | Washington Court House, OH | Internal Medicine | $115.01 |
| Wuhua Jing | New York, NY | Internal Medicine | $104.19 |
| Arthur Mcdermet | Pennsauken, NJ | Family Medicine | $93.79 |
| Andrew Baddoo | West Orange, NJ | Internal Medicine | $91.05 |
| Wayne Woo | Flowood, MS | Endocrinology, Diabetes & Metabolism | $89.27 |
| Donald Doran | Wiggins, MS | Family Medicine | $85.62 |
| Crystal Stafford | Wiggins, MS | Family | $85.62 |
| Deepinder Burn | Wiggins, MS | Internal Medicine | $85.62 |
| Denne Thomas-Patterson | Media, PA | Family Medicine | $78.80 |
| Steven Santangelo | Pennsauken, NJ | Family Medicine | $78.71 |
Prescribed Segluromet?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.